Galectin-9 interacts with PD-1 and TIM-3 to regulate T cell death and is a target for cancer immunotherapy

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Nature Communications

Topics

Biology

Biochemistry

Chemistry

Cancer Oncology

Immunology

Show all topics

DOI

10.1038/s41467-021-21099-2

License

CC-BY

Other Formats

PDF